Advocacy intelligence hub — real-time data for patient organizations
FINANCIAL LANDSCAPE SUMMARY
Total programs
VITRAKVI
(larotrectinib)Orphan drugstandardBayer HealthCare Pharmaceuticals Inc.
Kinase Inhibitor [EPC]
12.1 Mechanism of Action Larotrectinib is an inhibitor of the tropomyosin receptor kinases (TRK), TRKA, TRKB, and TRKC. In a broad panel of purified e...